Tak Cheung

Tak Cheung is a United States-based Partner at New Enterprise Associates (NEA), where he specializes in medical device investments for technology and healthcare startups. In this role, he executes venture capital deals ranging from $2 million to $50 million, with a typical investment size of $25 million. Before joining NEA in 2018, Cheung served as a Venture Partner at Merieux Development Venture Fund and was Vice President of Business Development at Bausch + Lomb. He also co-founded Lexington Medical and previously worked as Director of Business Development at Edwards Lifesciences and Corporate Development Manager at Advanced Medical Optics. His notable recent investment portfolio includes backing innovative companies such as Allay Therapeutics, Spyglass Ophthalmics, and Lungpacer Medical. Currently, Cheung leverages his deep operational experience to guide healthcare enterprises through cross-functional leadership, product launch, commercialization, and acquisition integration.